Company
Endochoice
Last checked: Nov 19, 2026Source: SEC EDGAR, openFDA and ClinicalTrials.govMethods & limitations
FDA decisions since 2015
9
510(k), De Novo and PMA
Device trials
3
As lead sponsor, any status
Adverse event reports
0
Received Nov 1, 2025 to Nov 20, 2026
Recall records
1
One per recalled product
This company is not on our public-company list, so only this exact name is matched. Naming a company here is not a recommendation of it or of any security.
Financing
Not publicly listed. It has raised money in private placements reported to the SEC on Form D (filings through 2026Q3). A company with no recent filing may since have been acquired.
Total raised (reported)
$12.1M
2 Form D offerings, 2010 to 2010
Equity
$12.1M
Stock sold for cash
Debt and convertible notes
$0
Loans and notes sold to investors
Last known valuation
Unknown
Form D filings do not report valuation
Latest round: equity, $4.5M raised of $4.7M sought, first sale Dec 30, 2010, 11 investors.
Funding rounds (Form D)
One row per Form D offering, newest first. The amount raised is the latest amended figure. An offering can run for months and close in several tranches. Matched by company name, so check the filing.
| First sale | Type | Raised | Round size | Investors | Exemption and agent | Filing |
|---|---|---|---|---|---|---|
| Dec 30, 2010 | Equity | $4.5M | $4.7M | 11 | Rule 506 | Form D ↗Jan 12, 2011 |
| Jun 15, 2010 | Equity | $7.6M | $7.8M | 10 | Rule 506 | Form D/A ↗Jun 29, 20101 amendment |
Company details
From the company's latest Form D.
- Legal name
- ENDOCHOICE, INC.
- Headquarters
- Alpharetta, Georgia
- Incorporated
- Delaware in 2007
- Entity type
- Corporation
- Revenue range
- Decline to Disclose
- Industry filed under
- Other Health Care
- SEC filer
- CIK 1423167 ↗
Executives, directors and promoters
As listed on the latest Form D.
13 more people on the filing with a free account
Not in public filings: valuations, share prices and investors' names. Private databases such as PitchBook and Crunchbase estimate these from press releases and surveys. Not every round is filed: companies raising under other exemptions, or from foreign investors only, may not file Form D. Nothing here is investment advice.
Investors
5%+ shareholders from SEC Schedule 13D/13G filings since Dec 1, 2024, and SBIR/STTR grants (NIH through Nov 10, 2026, other agencies through 2023). Venture investors in private rounds are not in public filings.
No 5%+ shareholder filings or SBIR grants found under the name Endochoice.
Latest FDA decisions
The 8 newest of 9 since 2015.
K160275 · Decided Aug 1, 2016 · 181 days after receipt
Device type: Endoscope, Accessories, Image Post-Processing For Color Enhancement (PEA) · GI, Urology & Nephrology
K161482 · Decided Jun 27, 2016 · 27 days after receipt
Device type: Pump, Air, Non-Manual, For Endoscope (FEQ) · GI, Urology & Nephrology
K161167 · Decided May 26, 2016 · 30 days after receipt
Device type: Endoscopic Irrigation/Suction System (OCX) · GI, Urology & Nephrology
6 more FDA decisions with a free account
Device trials
Trials on ClinicalTrials.gov that list this company as lead sponsor, most recently updated first.
NCT02651857 · 1,000 participants (planned) · Start Nov 2015 · Primary completion Apr 27, 2017
Device: Fuse® Colonoscope; Fuse® Gastroscope · For: Gastrointestinal Diseases
NCT02439502 · 29 participants · Start Apr 2015 · Primary completion Dec 2016
Device: Fuse® system · For: Miscellaneous Gastroenterology and Urology Devices Associated With Adverse Incidents, Not Elsewhere Classified
- A Study of EndoChoice's Upper&Lower Endoscopic Systems Utilizing a Full Spectrum Optical TechnologyCompleted
NCT02143284 · 30 participants · Start May 2014 · Primary completion Jan 2015
Device: Endoscopy exploratory single arm (EndoChoice FUSE(TM) System) · For: Gastrointestinal Diseases
Sites: Haifa, Israel
Reports received
0
Received Nov 1, 2025 to Nov 20, 2026
Malfunction reports
0
Injury reports
0
Death reports
0
Adverse event reports received per month
Reports that name this company as manufacturer, by the date FDA received them. The newest month is incomplete.
No reports to chart for this view.
Device types named most often
Last 12 months, by FDA product code. A company that sells more gets more reports.
No device types to rank.
Brand names named most often
Last 12 months, as written on the reports. One product can appear under several spellings.
No brand names to rank.
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
- Fuse 1C ColonoscopeTerminated
Z-0694-2016 · Started Dec 18, 2015 · Posted by FDA Jan 27, 2016
Reason given: The bending section of the device may partially separate from the insertion tube. Potential for tissue trauma.
Cause as FDA categorized it: Process design · Device type: Colonoscope And Accessories, Flexible/Rigid (FDF)
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.